Orphan designation: monoclonal antibody against human CD30 covalently linked to the cytotoxin monomethylauristatin E (brentuximab vedotin) Treatment of Hodgkin's lymphoma, 15/01/2009 Withdrawn

Orphan designation: monoclonal antibody against human CD30 covalently linked to the cytotoxin monomethylauristatin E Treatment of peripheral T-cell lymphoma, 21/08/2019 Withdrawn

Annex XV - List of topiramate containing medicinal products in the European Union

Annex XV - List of topiramate containing medicinal products in the European Union

List of medicinal products under additional monitoring

List of medicinal products under additional monitoring

MSSG recommendations on shortage of Glucagon-Like Peptide-1 (GLP-1) receptor agonists

EU actions to tackle shortages of GLP-1 receptor agonists

Human medicines European public assessment report (EPAR): Leflunomide Zentiva (previously Leflunomide Winthrop), leflunomide, Date of authorisation: 08/01/2010, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Fluenz, influenza vaccine (live attenuated, nasal), Date of authorisation: 03/06/2024, Status: Authorised